Results 231 to 240 of about 8,531 (253)
Digital speech biomarkers for assessing cognitive decline across neurodegenerative conditions
This study investigates speech impairments in individuals with mild cognitive impairment due to Alzheimer’s disease (MCI-AD), mild cognitive impairment with Lewy bodies (MCI-LB), and Parkinson’s disease with mild cognitive impairment (PD-MCI), compared ...
Daniel Kovac +2 more
exaly +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Intergroup Threat and the Linguistic Intergroup Bias: A Stress Biomarker Study
Journal of Language and Social Psychology, 2018This study investigates the physiological consequences of derogation. In the face of an ingroup threat, an opportunity to derogate the outgroup is associated with increases in salivary cortisol, a stress biomarker. These findings support the intergroup anxiety model, which suggests that following an anxiety-inducing threatening experience, outgroup ...
Sinthujaa Sampasivam +3 more
openaire +1 more source
Alzheimer's & Dementia, 2023
AbstractBackgroundThere is an urgent need for accessible biomarkers that can predict cognitive impairment in older individuals. There is also a complete lack of biomarkers for TAR DNA‐binding protein‐43 (TDP‐43), a frequent and important neurodegenerative pathology in older individuals, currently referred to as Limbic‐predominant Age‐related TDP‐43 ...
Bubbico, Giovanna +7 more
openaire +3 more sources
AbstractBackgroundThere is an urgent need for accessible biomarkers that can predict cognitive impairment in older individuals. There is also a complete lack of biomarkers for TAR DNA‐binding protein‐43 (TDP‐43), a frequent and important neurodegenerative pathology in older individuals, currently referred to as Limbic‐predominant Age‐related TDP‐43 ...
Bubbico, Giovanna +7 more
openaire +3 more sources
Neurobiology of Aging, 2020
We aimed to detail language profiles, brain metabolic patterns and proportion of Alzheimer's disease biomarkers in a cohort of patients with mixed primary progressive aphasia (mPPA). We considered 58 patients with PPA: 10 with non-fluent/agrammatic variant (nfvPPA), 16 with semantic variant (svPPA), 21 with logopenic variant (lvPPA) and 9 with mPPA ...
Mazzeo S. +13 more
openaire +3 more sources
We aimed to detail language profiles, brain metabolic patterns and proportion of Alzheimer's disease biomarkers in a cohort of patients with mixed primary progressive aphasia (mPPA). We considered 58 patients with PPA: 10 with non-fluent/agrammatic variant (nfvPPA), 16 with semantic variant (svPPA), 21 with logopenic variant (lvPPA) and 9 with mPPA ...
Mazzeo S. +13 more
openaire +3 more sources
IEEE Journal of Biomedical and Health Informatics
Psychiatric evaluation suffers from subjectivity and bias, and is hard to scale due to intensive professional training requirements. In this work, we investigated whether behavioral and physiological signals, extracted from tele-video interviews, differ in individuals with psychiatric disorders.Temporal variations in facial expression, vocal expression,
Zifan Jiang +7 more
openaire +2 more sources
Psychiatric evaluation suffers from subjectivity and bias, and is hard to scale due to intensive professional training requirements. In this work, we investigated whether behavioral and physiological signals, extracted from tele-video interviews, differ in individuals with psychiatric disorders.Temporal variations in facial expression, vocal expression,
Zifan Jiang +7 more
openaire +2 more sources
Linguistic biomarkers as a diagnostic and prognostic tool for identifying Alzheimer’s Disease
Methods: Utilizing a rich dataset from historical and ongoing Iowa Labor History Oral Project, this study employs machine learning techniques to analyze the spoken language features of participants categorized across a cognitive spectrum—from healthy aging to single domain amnestic MCI (aMCI) and multidomain aMCI. The research focuses on analyzing bothopenaire +1 more source
Abstract Introduction Recent success has been achieved in Alzheimer’s disease (AD) clinical trials targeting amyloid beta (β), demonstrating a reduction in the rate of cognitive decline. However, testing methods for amyloid-β positivity are currently costly or invasive, motivating the development of ...
Cole Robertson +5 more
openaire +2 more sources
Cole Robertson +5 more
openaire +2 more sources
Abstract Background Alzheimer’s disease (AD) causes progressive decline in language and cognition. Automated speech analysis has emerged as a promising screening tool, yet clinical data scarcity limits progress.
Akshita Debnath, Souhrid Sarkar
openaire +1 more source
Akshita Debnath, Souhrid Sarkar
openaire +1 more source
Background: Differentiating language impairments caused by neurological conditions such as left hemisphere damage (LHD), right hemisphere damage (RHD), dementia, Mild Cognitive Impairment (MCI), and Traumatic Brain Injury (TBI) is a clinical challenge.
Charalambos Themistocleous +1 more
openaire +1 more source
Charalambos Themistocleous +1 more
openaire +1 more source
Acoustic and Linguistic Biomarkers for Cognitive Impairment Detection from Speech
Interspeech 2025Catarina Botelho +13 more
openaire +1 more source

